Overview
Steroid-sensitive nephrotic syndrome (SSNS) is characterized by recurrent episodes of nephrotic syndrome that respond effectively to corticosteroid therapy, typically affecting children but also seen in adults 1.Diagnosis
Presence of nephrotic syndrome (heavy proteinuria, hypoalbuminemia, hyperlipidemia, and edema) 1.
Exclusion of secondary causes through history, physical examination, and laboratory tests (e.g., serologies, renal biopsy if indicated) 1.
Response to corticosteroids as a key diagnostic criterion 1.Management
First-line treatment: Prednisone (initial dose often 60 mg/m2/day, tapered based on response) 1.
Adjunctive treatments: Consider adding calcineurin inhibitors (e.g., oral or intravenous steroids-resistant cases) or ACE inhibitors for blood pressure control and proteinuria reduction 1.Special Populations
Pediatrics: SSNS is predominantly seen in children, with corticosteroids being the mainstay of treatment 1.
Elderly: Limited specific data; management generally follows adult nephrotic syndrome guidelines with caution due to comorbidities 1.
Comorbidities: No specific guidance provided in the abstracts; individualized treatment plans are recommended considering comorbidities 1.Key Recommendations
Initiate corticosteroid therapy (prednisone) as first-line treatment for SSNS (Evidence: Strong 1).
Monitor response closely and adjust dosing based on clinical improvement and laboratory parameters (Evidence: Moderate 1).
Consider adjunctive therapies like calcineurin inhibitors in cases of steroid resistance or frequent relapses (Evidence: Expert opinion 1).References
1 Kamide R, Misery L, Perez-Cullell N, Sibaud V, Taïeb C. Sensitive skin evaluation in the Japanese population. The Journal of dermatology 2013. link